
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16969289
[patent_doc_number] => 11065235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Substituted methanopyrido [2, 1-a] isoindolones as mAChR modulators for treating various associated pathophysiological conditions and process for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/614482
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9121
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614482 | Substituted methanopyrido [2, 1-a] isoindolones as mAChR modulators for treating various associated pathophysiological conditions and process for preparation thereof | May 17, 2018 | Issued |
Array
(
[id] => 18246764
[patent_doc_number] => 11603337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-14
[patent_title] => Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule
[patent_app_type] => utility
[patent_app_number] => 16/614009
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16546
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 517
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614009 | Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule | May 15, 2018 | Issued |
Array
(
[id] => 16839463
[patent_doc_number] => 20210147475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/612212
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612212 | Method for producing cyclic organic compound | May 10, 2018 | Issued |
Array
(
[id] => 13402367
[patent_doc_number] => 20180252726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
[patent_app_type] => utility
[patent_app_number] => 15/974921
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974921
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974921 | Methods and reagents for analyzing protein-protein interfaces | May 8, 2018 | Issued |
Array
(
[id] => 15073537
[patent_doc_number] => 10466249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Methods and reagents for analyzing protein-protein interfaces
[patent_app_type] => utility
[patent_app_number] => 15/974923
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 41673
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974923 | Methods and reagents for analyzing protein-protein interfaces | May 8, 2018 | Issued |
Array
(
[id] => 15960665
[patent_doc_number] => 20200164084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/608608
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608608 | ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES | Apr 26, 2018 | Abandoned |
Array
(
[id] => 16968756
[patent_doc_number] => 11064699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound or the salt, and method for using the insecticide
[patent_app_type] => utility
[patent_app_number] => 16/608080
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17359
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 526
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608080 | Condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound or the salt, and method for using the insecticide | Apr 25, 2018 | Issued |
Array
(
[id] => 17221750
[patent_doc_number] => 11174240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
[patent_app_type] => utility
[patent_app_number] => 16/605380
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6429
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605380 | Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride | Apr 19, 2018 | Issued |
Array
(
[id] => 17104296
[patent_doc_number] => 11124491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Process for the manufacture of vortioxetine HBr alpha-form
[patent_app_type] => utility
[patent_app_number] => 16/604313
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 4913
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604313 | Process for the manufacture of vortioxetine HBr alpha-form | Apr 19, 2018 | Issued |
Array
(
[id] => 16861661
[patent_doc_number] => 11020383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Methods for the treatment of cancer metastasis
[patent_app_type] => utility
[patent_app_number] => 16/606250
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18674
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606250 | Methods for the treatment of cancer metastasis | Apr 18, 2018 | Issued |
Array
(
[id] => 15649437
[patent_doc_number] => 20200087248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => Fluoroallylamine Derivative And Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/489474
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489474 | Fluoroallylamine Derivative And Use Thereof | Apr 18, 2018 | Abandoned |
Array
(
[id] => 15339593
[patent_doc_number] => 10525455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Catalyst composition and process for preparing olefin oxides
[patent_app_type] => utility
[patent_app_number] => 15/953659
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14342
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953659
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953659 | Catalyst composition and process for preparing olefin oxides | Apr 15, 2018 | Issued |
Array
(
[id] => 16009373
[patent_doc_number] => 20200179529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CYTOTOXIN AND CONJUGATE, USES OF SAME AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/497415
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497415 | Cytotoxin and conjugate, uses of same and preparation method therefor | Apr 11, 2018 | Issued |
Array
(
[id] => 16519440
[patent_doc_number] => 10870649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Synthesis of NIR fluorescent probe
[patent_app_type] => utility
[patent_app_number] => 16/604430
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604430 | Synthesis of NIR fluorescent probe | Apr 9, 2018 | Issued |
Array
(
[id] => 17287061
[patent_doc_number] => 11203601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/603112
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 48119
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 528
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603112 | Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof | Apr 4, 2018 | Issued |
Array
(
[id] => 16090231
[patent_doc_number] => 20200199102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/500702
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500702 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Apr 3, 2018 | Abandoned |
Array
(
[id] => 17098164
[patent_doc_number] => 20210285955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
[patent_app_type] => utility
[patent_app_number] => 16/500634
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -247
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500634 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | Apr 3, 2018 | Abandoned |
Array
(
[id] => 17604005
[patent_doc_number] => 11332476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Fms-like tyrosine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/630150
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15549
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630150 | Fms-like tyrosine kinase inhibitors | Apr 2, 2018 | Issued |
Array
(
[id] => 16763509
[patent_doc_number] => 20210109090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/499734
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499734 | Protease-activated contrast agents for in vivo imaging | Mar 29, 2018 | Issued |
Array
(
[id] => 16792949
[patent_doc_number] => 20210122766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => SALT FORMS OF AMINO PYRAZINE PURINE BASED SELECTIVE KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/497109
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497109 | Salt forms of amino pyrazine purine based selective kinase inhibitor | Mar 29, 2018 | Issued |